125 related articles for article (PubMed ID: 38448833)
1. Cutaneous melanoma in older patients.
Buja A; Rugge M; Trevisiol C; Zanovello A; Brazzale AR; Zorzi M; Vecchiato A; Del Fiore P; Tropea S; Rastrelli M; Rossi CR; Mocellin S
BMC Geriatr; 2024 Mar; 24(1):232. PubMed ID: 38448833
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous melanoma in adolescents and young adults.
Buja A; Rugge M; Trevisiol C; Zanovello A; Brazzale AR; Zorzi M; Vecchiato A; Del Fiore P; Tropea S; Chiarion-Sileni V; Rossi CR; Mocellin S
J Eur Acad Dermatol Venereol; 2024 May; ():. PubMed ID: 38709156
[TBL] [Abstract][Full Text] [Related]
3. Clinical performance indicators for monitoring the management of cutaneous melanoma: a population-based perspective.
Buja A; Rugge M; De Luca G; Zorzi M; Cozzolino C; Vecchiato A; Del Fiore P; Tropea S; Bortolami A; Benini P; Rossi CR; Mocellin S
Melanoma Res; 2022 Oct; 32(5):353-359. PubMed ID: 35855661
[TBL] [Abstract][Full Text] [Related]
4. Sex Differences in Cutaneous Melanoma: Incidence, Clinicopathological Profile, Survival, and Costs.
Buja A; Rugge M; Damiani G; Zorzi M; De Toni C; Vecchiato A; Del Fiore P; Spina R; Baldo V; Brazzale AR; Rossi CR; Mocellin S
J Womens Health (Larchmt); 2022 Jul; 31(7):1012-1019. PubMed ID: 35076310
[No Abstract] [Full Text] [Related]
5. Cutaneous Melanoma in Alpine Population: Incidence Trends and Clinicopathological Profile.
Buja A; Rugge M; De Luca G; Bovo E; Zorzi M; De Toni C; Cozzolino C; Vecchiato A; Del Fiore P; Spina R; Cinquetti S; Baldo V; Rossi CR; Mocellin S
Curr Oncol; 2022 Mar; 29(3):2165-2173. PubMed ID: 35323375
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study.
Ghazawi FM; Cyr J; Darwich R; Le M; Rahme E; Moreau L; Netchiporouk E; Zubarev A; Roshdy O; Glassman SJ; Sasseville D; Litvinov IV
J Am Acad Dermatol; 2019 Feb; 80(2):448-459. PubMed ID: 30092328
[TBL] [Abstract][Full Text] [Related]
7. The reduced mortality of malignant melanoma at the population level is mainly attributable to treatment advances for the past decade.
Li S; Tang T; Han J; Liu W; Chen R; Deng H; Jian T; Fu Z
Cancer Epidemiol; 2024 Feb; 88():102515. PubMed ID: 38176331
[TBL] [Abstract][Full Text] [Related]
8. Time trends in features of cutaneous melanoma at diagnosis: central-south Italy, 1962-1991.
Cavalieri R; Macchini V; Mostaccioli S; Sonego G; Ferranti G; Corona R; Fucci M; Marzolini F; Rosmini F; Pasquini P
Ann Ist Super Sanita; 1993; 29(3):469-72. PubMed ID: 8172468
[TBL] [Abstract][Full Text] [Related]
9. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
[TBL] [Abstract][Full Text] [Related]
10. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.
Huang K; Fan J; Misra S
J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Orfanos CE
Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
[TBL] [Abstract][Full Text] [Related]
12. Angiopoietin-2 expression and its relationship with lymphangiogenesis and clinicopathological characteristics in cutaneous malignant melanoma.
Zheng W; Ju W; Yang XH; Yan ZX
Front Oncol; 2023; 13():1113604. PubMed ID: 37519819
[TBL] [Abstract][Full Text] [Related]
13. Synchronous and metachronous multiple primary cancers in melanoma survivors: a gender perspective.
Guzzinati S; Buja A; Grotto G; Zorzi M; Manfredi M; Bovo E; Del Fiore P; Tropea S; Dall'Olmo L; Rossi CR; Mocellin S; Rugge M
Front Public Health; 2023; 11():1195458. PubMed ID: 37397750
[TBL] [Abstract][Full Text] [Related]
14. Analysis of disease free survival in cutaneous melanoma patients subject to sentinel lymph node biopsy.
Łobaziewicz W; Szloch J; Wajda J; Legkiy O; Marczyk E; Wysocki W
Pol Przegl Chir; 2020 Mar; 92(3):15-21. PubMed ID: 32759393
[TBL] [Abstract][Full Text] [Related]
15. Distinctive features of melanoma and its management in elderly patients: a population-based study in France.
Ciocan D; Barbe C; Aubin F; Granel-Brocard F; Lipsker D; Velten M; Dalac S; Truchetet F; Michel C; Mitschler A; Arnoult G; Buemi A; Dalle S; Bernard P; Woronoff AS; Grange F
JAMA Dermatol; 2013 Oct; 149(10):1150-7. PubMed ID: 23945633
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous malignant melanoma in south Sweden 1965, 1975, and 1985. A histopathologic review.
Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Cancer; 1994 Mar; 73(6):1625-30. PubMed ID: 8156490
[TBL] [Abstract][Full Text] [Related]
17. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
18. Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005.
Pruthi DK; Guilfoyle R; Nugent Z; Wiseman MC; Demers AA
J Am Acad Dermatol; 2009 Jul; 61(1):44-50. PubMed ID: 19395122
[TBL] [Abstract][Full Text] [Related]
19. Clinico-pathological Characteristics of Cutaneous Malignant Melanoma in Pakistan.
Khan RS; Shakeel O; Bhatti AF; Hussain R
J Coll Physicians Surg Pak; 2020 Nov; 30(11):1197-1200. PubMed ID: 33222740
[TBL] [Abstract][Full Text] [Related]
20. Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: Trends and correlations.
Bucchi L; Mancini S; Zamagni F; Crocetti E; Dal Maso L; Ferretti S; Baldacchini F; Giuliani O; Ravaioli A; Vattiato R; Brustolin A; Candela G; Carone S; Carrozzi G; Cavallo R; Dinaro YM; Ferrante M; Iacovacci S; Mazzoleni G; Musolino A; Rizzello RV; Serraino D; Biggeri A; Stanganelli I; Falcini F;
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):293-302. PubMed ID: 36181283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
